| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| XBP1P1 |
|
X-box binding protein 1 pseudogene 1
|
|
|
0.653 |
0.692 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR16-1 |
|
microRNA 16-1
|
|
|
0.623 |
0.500 |
| MIR200C |
|
microRNA 200c
|
|
|
0.486 |
0.846 |
| MIR203A |
|
microRNA 203a
|
|
|
0.471 |
0.808 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |